MRI Finds Brain Iron Level Differences in Children with ADHD
Magnetic resonance imaging may be a promising way to detect lower levels of iron in the brain, helping determine which children have ADHD.
Magnetic resonance imaging may help detect lower brain iron levels among children with attention deficit hyperactivity disorder (ADHD), according to a study published in the journal Radiology.
Researchers from the Medical University of South Carolina and New York University School of Medicine performed a prospective study designed to assess brain iron levels among children with ADHD.
“Much debate and concern has emerged regarding the continual rise of ADHD diagnosis in the U.S. given that two-thirds of those diagnosed receive psychostimulant medications,” co-author Vitria Adisetiyo, PhD, said in a release. “We wanted to see if we could identify brain iron as a potential noninvasive biomarker for medication-naïve ADHD to prevent misdiagnosis.”
Twenty-two children and adolescents with ADHD, 12 of whom were medication-naïve, and 27 healthy children and adolescents were enrolled in the study. All subjects aged in range from 8 to 18. All underwent MR imaging and serum iron measures were also collected.
Results showed that the medication-naïve subjects with ADHD “had significantly lower striatal and thalamic MFC [magnetic field correlation] indexes of brain iron than did control subjects and psychostimulant-medicated subjects with ADHD.” Both the control group and the medicated ADHD group had comparable MFC indexes. Blood serum levels were similar among all subjects.
“Our research suggests that iron absorption into the brain may be abnormal in ADHD given that atypical brain iron levels are found even when blood iron levels in the body are normal,” Adisetiyo said.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
Multinational Study Reaffirms Value of Adjunctive AI for Prostate MRI
June 16th 2025The use of adjunctive AI in biparametric prostate MRI exams led to 3.3 percent and 3.4 percent increases in the AUC and specificity, respectively, for clinically significant prostate cancer (csPCa) in a 360-person cohort drawn from 53 facilities.
Study: AI-Generated ADC Maps from MRI More Than Double Specificity in Prostate Cancer Detection
June 5th 2025Emerging research showed that AI-generated ADC mapping from MRI led to significant increases in accuracy, PPV and specificity in comparison to conventional ADC mapping while achieving a 93 percent sensitivity for PCa.
